2011
DOI: 10.1377/hlthaff.2011.0382
|View full text |Cite
|
Sign up to set email alerts
|

Estimated Economic Benefits During The ‘Decade Of Vaccines’ Include Treatment Savings, Gains In Labor Productivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
48
0
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 81 publications
(50 citation statements)
references
References 21 publications
1
48
0
1
Order By: Relevance
“…In this decade, expanding the delivery of six life-saving vaccines against pneumococcal disease, Haemophilus influenzae type b (Hib), rotavirus, pertussis, measles and malaria (projected first use in 2015) in 72 low-and middle-income countries could save 6.4 million lives, avoid 426 million cases of illness and prevent 63,000 children from being disabled. 27 Furthermore, the economic impact of vaccines to the family can also be very compelling. Vaccines are not only life-saving, but they are also a smart economic investment.…”
Section: Recommendationsmentioning
confidence: 99%
See 1 more Smart Citation
“…In this decade, expanding the delivery of six life-saving vaccines against pneumococcal disease, Haemophilus influenzae type b (Hib), rotavirus, pertussis, measles and malaria (projected first use in 2015) in 72 low-and middle-income countries could save 6.4 million lives, avoid 426 million cases of illness and prevent 63,000 children from being disabled. 27 Furthermore, the economic impact of vaccines to the family can also be very compelling. Vaccines are not only life-saving, but they are also a smart economic investment.…”
Section: Recommendationsmentioning
confidence: 99%
“…Between 2011 and 2020, increased rates of vaccination against the six aforementioned vaccines in 72 of the poorest countries could save $6.2 billion (uncertainty range: $4.8-9.2 billion) in treatment costs and $145 billion ($130-175 billion) in productivity losses. 27 To reduce the risk of 6.4 million deaths, people in those 72 countries would be willing to trade off incomes totaling $231 billion ($116-614 billion), a real measure of the value communities place on vaccines. 28 Systematic reviews of the vaccine economics literature suggest that vaccines are costeffective by World Health Organization and World Bank standards in most settings.…”
Section: Recommendationsmentioning
confidence: 99%
“…Las condiciones de salud en la infancia y el embarazo pueden limitar el crecimiento del PIB; hacer frente a estas condiciones puede revertir este efecto. [69][70][71][72][73] Existe un debate constante acerca del impacto macroeconómico de aumentar el número de personas que trabajan en el sector salud. Algunas investigaciones sugieren que daña la economía (si el alza de los salarios supera la productividad), algunas otras muestran que no hay efecto y otras sugieren que incluso puede estimular la economía.…”
Section: Wish-qatarorg/wish-2016/forum-reports)unclassified
“…Second, the existing reviews demonstrate that new research is needed to produce more robust evidence on the full benefits of vaccination. A number of scholars around the world have started to conduct such studies (19,31,33,(50)(51)(52)(53)(54)(55). Table 2 provides an overview of the emerging research on the full benefits of vaccination.…”
Section: Value Of Vaccination: Building the Evidence Basementioning
confidence: 99%